tiprankstipranks
Trending News
More News >
Panbela Therapeutics (PBLA)
OTHER OTC:PBLA
US Market

Panbela Therapeutics (PBLA) Financial Statements

Compare
243 Followers

Panbela Therapeutics Financial Overview

Panbela Therapeutics's market cap is currently $242.74K. The company's EPS TTM is $; its P/E ratio is >-0.01; Panbela Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -25.65M$ -35.73M$ -10.01M$ -5.75M$ -4.32M
Operating Income$ -51.29M$ -34.09M$ -10.01M$ -5.75M$ -4.32M
EBITDA$ -51.29M$ -34.74M$ -10.61M$ -5.05M$ -4.42M
Net Income$ -25.26M$ -34.93M$ -10.13M$ -4.77M$ -6.20M
Balance Sheet
Cash & Short-Term Investments$ 2.58M$ 1.28M$ 11.87M$ 9.02M$ 2.45M
Total Assets$ 11.80M$ 4.98M$ 12.87M$ 9.81M$ 3.14M
Total Debt$ 5.19M$ 6.84M$ 0.00$ 0.00$ 116.00K
Net Debt$ 2.62M$ 5.56M$ -11.87M$ -9.02M$ -2.33M
Total Liabilities$ 16.51M$ 13.03M$ 2.66M$ 1.36M$ 1.76M
Stockholders' Equity$ -4.71M$ -8.05M$ 10.21M$ 8.45M$ 1.39M
Cash Flow
Free Cash Flow$ -25.25M$ -15.94M$ -6.70M$ -3.85M$ -2.74M
Operating Cash Flow$ -25.25M$ -15.28M$ -6.70M$ -3.85M$ -2.74M
Investing Cash Flow$ 400.00K$ -656.00K$ -540.00K$ 0.00$ 0.00
Financing Cash Flow$ 26.14M$ 5.35M$ 10.10M$ 10.44M$ 3.78M
Currency in USD

Panbela Therapeutics Earnings and Revenue History

Panbela Therapeutics Debt to Assets

Panbela Therapeutics Cash Flow

Panbela Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.